Pharmaceutical Intermediates
- • Analgesics (57)
- • Anesthetics (52)
- • Anti-Addiction Agents (8)
- • Antibacterials (117)
- • Anticonvulsants (20)
- • Antidementia Agents (23)
- • Antidepressants (35)
- • Antiemetics (24)
- • Antifungals (24)
- • Antigout Agents (9)
- • Anti-inflammatory Agents (28)
- • Antimigraine Agents (21)
- • Antineoplastics (427)
- • Antiparasitics (11)
- • Antiparkinson Agents (28)
- • Antipsychotics (54)
- • Antispasticity Agents (12)
- • Antivirals (146)
- • Anxiolytics (16)
- • Blood Glucose Regulators (105)
- • Blood Products (61)
- • Cardiovascular Agents (179)
- • CNS Agents (22)
- • Dental and Oral Agents (8)
- • Dermatological Agents (19)
- • Electrolytes (15)
- • Gastrointestinal Agents (62)
- • Genetic/Enzyme Disorder (12)
- • Genitourinary Agents (47)
- • Immunological Agents (36)
- • Metabolic Bone Disease (6)
- • Ophthalmic Agents (343)
- • Respiratory Tract (51)
- • Skeletal Muscle Relaxants (5)
- • Sleep Disorder Agents (28)
- • Oled Material Intermediate (333)
- • Heterocyclic Compound (9764)
- • Bulk Drug Intermediates (17727)
Related News
-
India Imposes Final Anti‑Dumping Duties on Ethylenediamine from China, EU, Saudi Arabia, and Taiwan, China, with Top Rate of $575/tonne
2026-06-30 -
US Chemical Shutdown Wave Expands, PS Units Become the Hardest Hit Segment
2026-06-30 -
Haldia Petrochemicals Pipeline Fire in India Adds Uncertainty to Asia's Naphtha Market
2026-07-03 -
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
2026-06-26 -
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
2026-06-26 -
Another Major Coating Manufacturer Acquired by a Central SOE: BNBM Acquires SUNROAD Group for Over RMB 300 Million, Locks in Three-Year Performance Pledge
2026-06-29
Anxiolytics Intermediates
Anxiolytics
-
![buy 2-methyl-D-proline hydrochloride salt 98.0%Min RC00464]( "2-methyl-D-proline hydrochloride salt 98.0%Min RC00464")
Pharmaceutical Grade / 98.0%
-
![buy D-Proline, 2-methyl-, hydrochloride]( "D-Proline, 2-methyl-, hydrochloride")
Industrial Grade,Pharma Grade / 99%
-
![buy D-Proline, 2-methyl-, hydrochloride]( "D-Proline, 2-methyl-, hydrochloride")
- / 99.00%
-
![buy D-Proline, 2-methyl-, hydrochloride]( "D-Proline, 2-methyl-, hydrochloride")
Industrial Grade / 99.0%
Request for quotation , get quotes from more suppliers.
More Information
Anxiolytics are a class of drugs used to relieve anxiety, tension, and related psychological or somatic symptoms. They are essential in the treatment of generalized anxiety disorder (GAD), panic disorder, social anxiety, and insomnia. These agents help restore neurotransmitter balance in the central nervous system, promoting calmness and emotional stability.
Key categories include:
• Benzodiazepines (e.g., Diazepam, Lorazepam): Enhance GABA activity to produce rapid calming effects.
• Non-benzodiazepine anxiolytics (e.g., Buspirone): Act on serotonin receptors, providing long-term anxiety relief without strong sedation.
• Antihistamines (e.g., Hydroxyzine): Reduce anxiety through H1 receptor blockade with additional sedative properties.
• Certain antidepressants (e.g., SSRIs, SNRIs): Used off-label as first-line options for chronic anxiety management.
• Beta-blockers (e.g., Propranolol): Control physical symptoms such as tremors and rapid heartbeat, especially in performance anxiety.
When selecting anxiolytic raw materials, manufacturers should evaluate purity, solubility, pharmacological stability, and compliance with international standards. Materials are often supplied in powder, crystalline, or solution form, and can be formulated into oral tablets, capsules, or injectables depending on therapeutic needs.
Frequently Asked Questions
Anxiolytics are medications primarily used to treat anxiety disorders by affecting neurotransmitters in the brain, such as GABA (gamma-aminobutyric acid). They help reduce excessive nervousness, tension, and fear. Common classes include benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), and beta-blockers. Understanding their mechanism of action is essential for safe and effective use under medical supervision.
The most commonly prescribed anxiolytics include:1. Benzodiazepines (e.g., diazepam, alprazolam) – fast-acting but with potential for dependence.2. SSRIs (e.g., sertraline, escitalopram) – preferred for long-term anxiety management.3. SNRIs (e.g., venlafaxine) – also used for generalized anxiety disorder.4. Buspirone – a non-benzodiazepine option with lower abuse potential.5. Beta-blockers (e.g., propranolol) – used for situational anxiety like performance anxiety.Choice depends on symptom severity, patient history, and treatment goals.
Yes, several natural or herbal supplements are used as mild anxiolytic alternatives, including:• Valerian root• Passionflower• Lemon balm• Ashwagandha• L-theanine (found in green tea)While these may help with mild anxiety, they are not substitutes for clinically diagnosed anxiety disorders. Always consult a healthcare provider before combining herbal remedies with prescription medications due to potential interactions.
Common side effects of anxiolytics vary by class but may include:• Drowsiness or sedation (especially with benzodiazepines)• Dizziness or lightheadedness• Cognitive impairment or memory issues• Dependency or withdrawal symptoms with long-term benzodiazepine use• Nausea or sexual dysfunction (with SSRIs/SNRIs)Patients should be monitored closely, especially during treatment initiation or dosage changes, to manage adverse effects effectively.
Selecting the right anxiolytic involves a comprehensive evaluation by a qualified healthcare professional, considering factors such as:1. Type and severity of the anxiety disorder2. Patient’s medical and psychiatric history3. Risk of substance misuse or dependency4. Potential drug interactions with current medications5. Treatment duration (short-term vs. long-term needs)Shared decision-making between patient and provider ensures safe, personalized, and evidence-based care.